Glucagon and Urinary retention - a phase IV clinical study of FDA data

Summary:

Urinary retention is reported as a side effect among people who take Glucagon (glucagon hydrochloride), especially for people who are male, 60+ old, also take Vasotec, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Urinary retention when taking Glucagon. It is created by eHealthMe based on reports of 4,289 people who have side effects when taking Glucagon from the FDA, and is updated regularly.

What is Glucagon?

Glucagon has active ingredients of glucagon hydrochloride. eHealthMe is studying from 4,297 Glucagon users. Check the latest studies of Glucagon.

What is Urinary retention?

Urinary retention (the inability to completely or partially empty the bladder) is found to be associated with 1,569 drugs and 1,737 conditions by eHealthMe. Check the latest studies of Urinary retention.

On Jul, 19, 2026

4,289 people reported to have side effects when taking Glucagon.
Among them, 15 people (0.35%) have Urinary retention.

Among these 15 people:

What is the gender of people who have Urinary retention when taking Glucagon? *

female: 13.33 %
male: 86.67 %

What is the age of people who have Urinary retention when taking Glucagon? *

What are other drugs people take besides Glucagon? *

What are other side effects people have besides Urinary retention? *

Enlarged Prostate: 6 people, 40.00%
Urinary Tract Infection: 6 people, 40.00%
Diarrhea: 6 people, 40.00%
Nausea And Vomiting: 5 people, 33.33%
Cardiac Failure Congestive: 4 people, 26.67%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 26.67%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 26.67%
Hepatitis Cholestatic (flow of bile from the liver is slowed or blocked): 4 people, 26.67%
General Physical Health Deterioration (weak health status): 4 people, 26.67%
Gallstones (stone formation by bile component): 4 people, 26.67%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 3 people, 20.00%
Delusion (a false belief or opinion): 2 people, 13.33%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 13.33%
Soft Tissue Neoplasm (tumour of soft tissue): 2 people, 13.33%
Stress And Anxiety: 1 person, 6.67%
Hyperkalemia (damage to or disease of the kidney): 1 person, 6.67%
Colorectal Cancer Stage Iv (cancer of colon and rectal spreads to liver or lung): 1 person, 6.67%
Device Failure: 1 person, 6.67%
Discomfort: 1 person, 6.67%
Fever: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Glucagon and have Urinary retention?

- Check whether Urinary retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glucagon:

Glucagon (4,297 reports)

Browse all side effects of Glucagon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary retention:

Urinary retention (1,569 drugs)

Browse all the conditions that are associated with Urinary retention:

Urinary retention (1,737 conditions)

Related publications that referenced our studies

Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on glucagon hydrochloride (the active ingredients of Glucagon) and Glucagon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.